Weiwei Kong
- Co-authors
- Dong ChenPeng QuWenli XieDing‐Xiang YanKun DaiTing WangJiefeng GaoZhong‐Ming Li
- Topics
- Pancreatic and Hepatic Oncology Research (12 papers)Cancer Immunotherapy and Biomarkers (7 papers)Cancer Genomics and Diagnostics (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiwei Kong
65 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 123
- Molecular Biology 429
- Cancer Research 185
- Immunology 155
- Biomedical Engineering 127
- Surgery 112
Countries citing papers authored by Weiwei Kong
This map shows the geographic impact of Weiwei Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Kong more than expected).
Fields of papers citing papers by Weiwei Kong
This network shows the impact of papers produced by Weiwei Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Kong. The network helps show where Weiwei Kong may publish in the future.
Co-authorship network of co-authors of Weiwei Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Kong. A scholar is included among the top collaborators of Weiwei Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Kong. Weiwei Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 0 | |
| 11 | 4 | |
| 12 | 109 | |
| 13 | 7 | |
| 14 | 4 | |
| 15 | 41 | |
| 16 | 2 | |
| 17 | 2 | |
| 18 | 80 | |
| 19 | 20 | |
| 20 | 10 |
About Weiwei Kong
Weiwei Kong is a scholar working on Cancer Research, Transplantation and Oncology, having authored 75 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (12 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (185 citations), Nephrology (58 citations) and Polymers and Plastics (103 citations). Weiwei Kong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Dong Chen, Peng Qu, Wenli Xie, Ding‐Xiang Yan, Kun Dai, Ting Wang, Jiefeng Gao, Zhong‐Ming Li, Wan-Cheng Yu and Congcong Jiao. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.